MarketFriction

Indraprastha Medical Corporation Ltd

NSE INDRAMEDCO · BSE 532150 · Hospital
₹338.60 -2.97%
NSE close2026-10-01
52 week range340.20 - 640.85
Market cap₹3,256 Cr.
P/E17.3
Price band 20% Delivery 54.0%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales317306315348350325334365381372365406
Expenses267259266281286273272292310310304326
Operating Profit504748676452617371626180
OPM %16%15%15%19%18%16%18%20%19%17%17%20%
Other Income445565677778
Interest112222122112
Depreciation101010111111111011111112
Profit before tax444142605745556866565575
Tax %25%28%25%25%26%26%26%25%25%27%24%25%
Net Profit332931454233415149414256
EPS in Rs3.583.213.404.884.633.584.475.615.404.474.556.09
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales7557667537888316138881,0991,2451,3561,4831,524
Expenses6756866787067435727689471,0501,1121,2151,250
Operating Profit807974828741120152195245267274
OPM %11%10%10%10%11%7%14%14%16%18%18%18%
Other Income1-0-1-1-0-0-3916222830
Interest789763344666
Depreciation353131303333353940444445
Profit before tax3941344548479117166216246253
Tax %37%36%38%36%9%46%26%26%25%26%25%
Net Profit242621284425986124161184188
EPS in Rs2.662.862.303.104.760.256.399.4013.5217.5620.0320.51
Dividend Payout %68%63%65%52%0%0%39%32%33%26%20%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth7%19%11%11%
Compounded Profit Growth22%132%28%12%
Stock Price CAGR21%35%28%-20%
Return on Equity21%27%29%27%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital929292929292929292929292
Reserves103132139141152176181234288386505649
Borrowings50526766214352343337
Other Liabilities196185160134157177157131173212222214
Total Liabilities442460458432422449432462555723852991
Fixed Assets286301296294280303283277275347328365
CWIP3300103030333
Investments000000000000
Other Assets153157163138141146145185278376491624
Total Assets442460458432422449432462555723852991
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity6462284875862794144200157167
Cash from Investing Activity-29-33-22-30-17-40-19-74-108-158-111-178
Cash from Financing Activity-35-30-5-17-44-43-3-3-26-32-46-46
Net Cash Flow-0-0-01144517119-0-57
Free Cash Flow35295175846665100131120108
CFO/OP98%104%57%82%110%113%88%95%102%127%89%88%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days404147413535401823172028
Inventory Days
Days Payable
Cash Conversion Cycle404147413535401823172028
Working Capital Days-35-22-17-7-5-10-1-2-12-24-19-4
ROCE %23%18%17%15%19%21%3%29%34%38%39%36%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%51.00%
FIIs0.81%0.95%1.08%1.70%2.64%2.88%2.94%2.73%2.41%2.72%2.43%2.77%
DIIs6.71%6.36%4.91%3.14%3.19%3.18%3.56%3.56%3.51%0.82%0.87%0.59%
Public41.49%41.69%43.01%44.14%43.16%42.91%42.50%42.74%43.08%45.43%45.69%45.65%
No. of Shareholders47,86551,44854,15855,10364,67169,69770,49170,21170,91471,22572,98075,098

Fundamentals

Market Cap₹ 3,256 Cr.
Current Price₹ 355
Stock P/E17.3
Book Value₹ 80.8
ROCE35.8 %
ROE27.4 %
Dividend Yield1.13 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)11%
Compounded Profit Growth (TTM)12%
Standalone figures.
Valuation
Market capRs 3,104 Cr
Enterprise valueRs 2,878 Cr
P/E (TTM)16.51x
Price to book4.19x
Price to sales2.04x
EV / EBITDA9.47x
EV / EBIT11.13x
EV / sales1.89x
Price to cash flow18.54x
Earnings yield6.06%
Dividend yield1.18%
P/E, 3-year average17.75x
P/B, 3-year average4.61x
P/E, 5-year average14.12x
P/B, 5-year average3.47x
Profitability
Operating margin (excl. other income)18.04%
Operating margin (incl. other income)19.94%
EBITDA margin19.94%
Pre-tax margin16.57%
Net profit margin12.34%
Net margin, latest quarter13.75%
ROE27.47%
ROCE35.84%
ROA19.93%
ROE, 3-year average28.79%
ROCE, 3-year average37.64%
ROA, 3-year average19.92%
ROE, 5-year average26.08%
ROCE, 5-year average34.85%
ROA, 5-year average17.97%
ROIC (approx.)37.56%
Tax rate25.36%
Other income / net worth3.81%
Growth
Sales growth (latest year)9.30%
Profit growth (latest year)14.06%
Sales CAGR, 3 years10.50%
Sales CAGR, 5 years19.30%
Profit CAGR, 3 years28.69%
Profit CAGR, 5 years139.50%
Sales growth QoQ11.33%
Profit growth QoQ33.93%
Sales growth YoY (latest quarter)11.26%
Profit growth YoY (latest quarter)8.53%
Per share
EPS (TTM)Rs 20.51
EPS (latest year)Rs 20.03
EPS (latest quarter)Rs 6.09
EPS, 3-year averageRs 17.04
EPS, 5-year averageRs 13.38
Book value per shareRs 80.76
Sales per shareRs 166.20
Cash flow per shareRs 18.26
Free cash flow per shareRs 11.78
Dividend per share (latest year)Rs 4.00
Dividend per share, 3-year averageRs 4.33
Dividend per share, 5-year averageRs 3.70
Dividends
Dividend payout19.97%
Dividend payout, 3-year average26.29%
Dividend payout, 5-year average29.98%
Efficiency
Asset turnover1.50x
Fixed asset turnover4.06x
Inventory turnover45.84x
Inventory days8 days
Debtor days28 days
Debtors turnover13.22x
Cash conversion cycle28 days
Working capital days-4 days
Leverage
Total debtRs 37 Cr
Cash and bankRs 263 Cr
Net debtRs -226 Cr
Debt to equity0.05x
Net debt / EBITDA-0.75x
Interest coverage42.33x
Current ratio (filing 2026-03-31)2.46x
Quick ratio (filing 2026-03-31)2.41x
Trade payables (filing 2026-03-31)Rs 128 Cr
Owners' fund to total sources74.68%
Debt to assets3.72%
Cash flow
Cash from Operating Activity (latest year)Rs 167 Cr
Cash from Investing Activity (latest year)Rs -178 Cr
Cash from Financing Activity (latest year)Rs -46 Cr
Net Cash Flow (latest year)Rs -57 Cr
Free cash flow (latest year)Rs 108 Cr
FCFE (approx.: FCF + change in debt)Rs 112 Cr
Cash from ops / profit, 5 years1.24x
Sales to cash flow8.85x
Statement figures
Net sales (TTM)Rs 1,524 Cr
Net sales (latest year)Rs 1,483 Cr
Sales (latest quarter)Rs 406 Cr
Operating profit excl. other income (latest year)Rs 267 Cr
Operating profit (latest quarter)Rs 80 Cr
Other income (TTM)Rs 30 Cr
EBITDA (TTM)Rs 304 Cr
PBDT (TTM)Rs 298 Cr
Profit before tax (TTM)Rs 253 Cr
Tax (latest year)Rs 62 Cr
Net profit (TTM)Rs 188 Cr
Net profit (latest year)Rs 184 Cr
Net profit (latest quarter)Rs 56 Cr
Depreciation (TTM)Rs 45 Cr
Depreciation (latest quarter)Rs 12 Cr
Interest (TTM)Rs 6 Cr
Cost of goods sold (latest year)Rs 360 Cr
Total expenditure (latest year)Rs 1,215 Cr
Total income (latest year)Rs 1,511 Cr
Share capitalRs 92 Cr
ReservesRs 649 Cr
Shareholders' fundsRs 740 Cr
Total assetsRs 991 Cr
Net blockRs 365 Cr
Capital work in progressRs 3 Cr
ReceivablesRs 112 Cr
InventoryRs 8 Cr
Other liabilitiesRs 214 Cr
Shares outstanding (crore)9.17
Ownership
Promoter holding51.00% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 16.5 is at the 35th percentile of its own 9.4-year range (median 18.1, low 8.6, high 331.7).
P/B 4.19 is at the 69th percentile (median 2.23).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodINDRAMEDCONifty 50Difference
1 week-8.6%-2.8% -5.8 pts
1 month-5.4%-6.8% +1.4 pts
3 months-12.9%-7.6% -5.2 pts
6 months-9.1%+0.4% -9.5 pts
1 year-25.3%-9.9% -15.4 pts
2 years-24.7%-13.6% -11.2 pts
3 years+101.7%+14.2% +87.6 pts
5 years+329.2%+27.9% +301.3 pts
2 mutual fund schemes hold about ₹0 Cr. Over three months 0 bought more and 0 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Bandhan BSE Healthcare Index Fund0.10%0 +3%
Motilal Oswal BSE 1000 Index Fund0.01%0 +2%

Red flags

F-score 4 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹406 Cr +11.2% vs Jun 2025. Net profit ₹56 Cr +9.8%.
Against our estimate for Jun 2026: sales -0.6%, profit +12.6% beat. Our estimate for Sep 2026: sales Rs 420 Cr, profit Rs 51 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Apollo Hospitals Enterprise Ltd124,50359.217.4 %
Manipal Health Enterprises Ltd98,35711112.1 %
Max Healthcare Institute Ltd95,58963.814.7 %
Aster DM Quality Care Ltd63,97617711.6 %
Fortis Healthcare Ltd62,05858.213.4 %
Global Health Ltd38,04866.417.4 %
Narayana Hrudayalaya Ltd36,57942.415.5 %
Krishna Institute of Medical Sciences Ltd32,3361559.50 %
Dr Agarwals Health Care Ltd15,70110610.9 %
Rainbow Childrens Medicare Ltd13,89248.517.4 %
Park Medi World Ltd11,89842.819.5 %
Yatharth Hospital & Trauma Care Services Ltd10,67658.912.9 %
Healthcare Global Enterprises Ltd10,5052188.30 %
Jupiter Life Line Hospitals Ltd8,59144.914.8 %
Kovai Medical Center & Hospital Ltd6,57925.722.6 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-09-18Dividend - Rs 4 Per Share
2025-09-18Dividend - Rs 4.50 Per Share
2024-09-13Annual General Meeting/Dividend - Rs 4.50 Per Share
2023-09-15Annual General Meeting/Dividend - Rs 3 Per Share
2022-09-15Annual General Meeting/Dividend - Rs 2.50 Per Share
2021-09-16 Annual General Meeting
2020-09-17 Annual General Meeting
2019-09-12 Annual General Meeting/Dividend - Rs 1.60 Per Sh
2018-09-12 Annual General Meeting/Dividend- Rs 1.50 Per Share
2017-09-14 Annual General Meeting/Dividend - Rs 1.80 Per Share
2016-08-18 Annual General Meeting/ Dividend - Rs 1.80/- Per Share
2015-09-16 Annual General Meeting / Dividend Rs 1.80/- Per Share
2014-09-18Annual General Meeting / Dividend - Rs 1.80/- Per Share
2013-09-19Annual General Meeting / Dividend - Rs 1.60/- Per Share
2012-09-06Annual General Meeting And Dividend Rs.1.60 Per Share
2011-09-05Dividend Rs 1.60 Per Share
2010-08-30Annual General Meeting And Dividend Rs.1.60 Per Share
2009-08-27Dividend-Rs.1.50 Pr Share
2008-08-28Agm/Dividend - 14%
2007-09-07Agm/Dividend-12.5%
2006-07-28Agm/Dividend-12.5%
DateTypeWhat it says
2026-09-25Shareholder meetingVoting results.
2026-09-24Shareholder meetingProceedings of Annual General Meeting held on September 24, 2026
2026-09-01Shareholder meetingNotice of Annual General Meeting to be held on September 24, 2026
2026-08-29Record DateRecord date for the purpose of Dividend is 18-Sep-2026.
2026-08-29General UpdatesGeneral Updates
2026-08-06General UpdatesGeneral Updates
2026-08-06Record DateRecord date for the purpose of Dividend & Meeting is 18-Sep-2026.
2026-08-06Board meeting outcomeIndraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-06-19Disclosure under SEBI TakeovAPOLLO HOSPITALS ENTERPRISE LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of ...
2026-06-02Concall / analyst meetSchedule of meet
2026-05-27Credit RatingCredit Rating
2026-05-12DividendBoard of Directors at its meeting held on May 12, 2026, recommended Final Dividend of Rs. 4 per equity share.
2026-05-12Board meeting outcomeIndraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-04-01Director changeChange in Director(s) of the company.
2026-03-21Shareholder meetingVoting results.
2026-02-18Shareholder meetingNotice of Postal Ballot
2026-02-09Updates.
2026-02-03AppointmentAppointment of Ms Madhumita Ganguli as Non- Executive Independent Director of the company w.e.f. Jun 09, 2026.
2026-02-03AppointmentAppointment of Ms Vineeta Rai as Non- Executive Independent Director of the company w.e.f. February 08, 2026.
2026-02-03AppointmentAppointment of Mr Mr. Salil Singhal as Non- Executive Independent Director of the company w.e.f. February 08, 2026.
2026-02-03AppointmentAppointment of Mr Mr. Harsh Pati Singhania as Non- Executive Independent Director of the company w.e.f. February 03, 2026.
2026-02-03Board meeting outcomeIndraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
2025-11-10Concall / analyst meetSchedule of meet
2025-11-10Concall / analyst meetSchedule of meet
2025-11-01Board meeting outcomeIndraprastha Medical Corporation Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.

Quick answers

What is the market cap of Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd (INDRAMEDCO) has a market capitalisation of Rs 3,256 Cr. at the 2026-10-01 close.

What is the P/E ratio of Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd trades at a P/E of 17.3 on trailing twelve-month profit, at the 2026-10-01 close.

What were Indraprastha Medical Corporation Ltd's latest quarterly results?

In the Jun 2026 quarter, Indraprastha Medical Corporation Ltd sales was Rs 406 Cr (+11.2% vs Jun 2025) and net profit was Rs 56 Cr.

What is the 52-week high and low of Indraprastha Medical Corporation Ltd?

The 52-week high is Rs 640.85 and the 52-week low is Rs 340.20.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03